SOFOSBUVIR\VELPATASVIR: 18,042 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
18,042
Total FAERS Reports
978 (5.4%)
Deaths Reported
2,342
Hospitalizations
18,042
As Primary/Secondary Suspect
143
Life-Threatening
289
Disabilities
First Report: 1985 · Latest Report: 20250912
What Are the Most Common SOFOSBUVIR\VELPATASVIR Side Effects?
#1 Most Reported
Fatigue
3,666 reports (20.3%)
#2 Most Reported
Headache
3,084 reports (17.1%)
#3 Most Reported
Nausea
1,637 reports (9.1%)
All SOFOSBUVIR\VELPATASVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 3,666 | 20.3% | 15 | 129 |
| Headache | 3,084 | 17.1% | 5 | 110 |
| Nausea | 1,637 | 9.1% | 3 | 98 |
| Diarrhoea | 882 | 4.9% | 10 | 55 |
| Insomnia | 715 | 4.0% | 2 | 34 |
| Drug ineffective | 694 | 3.9% | 17 | 54 |
| Product dose omission issue | 625 | 3.5% | 1 | 69 |
| Death | 597 | 3.3% | 591 | 59 |
| Hepatitis c | 510 | 2.8% | 14 | 38 |
| Vomiting | 507 | 2.8% | 9 | 94 |
| Intentional dose omission | 474 | 2.6% | 3 | 112 |
| Dizziness | 427 | 2.4% | 6 | 42 |
| Treatment failure | 380 | 2.1% | 3 | 18 |
| Product dose omission | 364 | 2.0% | 0 | 31 |
| Abdominal discomfort | 356 | 2.0% | 5 | 23 |
| Rash | 321 | 1.8% | 3 | 28 |
| Pain | 310 | 1.7% | 4 | 31 |
| Asthenia | 306 | 1.7% | 16 | 77 |
| Dyspepsia | 301 | 1.7% | 1 | 9 |
| Decreased appetite | 279 | 1.6% | 4 | 30 |
Who Reports SOFOSBUVIR\VELPATASVIR Side Effects? Age & Gender Data
Gender: 42.5% female, 57.5% male. Average age: 54.5 years. Most reports from: US. View detailed demographics →
Is SOFOSBUVIR\VELPATASVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2008 | 1 | 1 | 1 |
| 2009 | 1 | 0 | 0 |
| 2012 | 1 | 0 | 0 |
| 2014 | 2 | 0 | 1 |
| 2016 | 439 | 10 | 58 |
| 2017 | 2,113 | 77 | 241 |
| 2018 | 1,917 | 103 | 221 |
| 2019 | 2,752 | 95 | 299 |
| 2020 | 1,539 | 68 | 189 |
| 2021 | 672 | 61 | 152 |
| 2022 | 477 | 54 | 120 |
| 2023 | 306 | 28 | 95 |
| 2024 | 222 | 39 | 45 |
| 2025 | 122 | 14 | 39 |
What Is SOFOSBUVIR\VELPATASVIR Used For?
| Indication | Reports |
|---|---|
| Chronic hepatitis c | 6,405 |
| Hepatitis c | 4,956 |
| Product used for unknown indication | 2,083 |
| Hepatic cirrhosis | 368 |
| Hepatitis viral | 99 |
| Hepatitis c virus test positive | 88 |
| Hepatitis b | 46 |
| Essential hypertension | 33 |
| Acute hepatitis c | 29 |
| Chronic hepatitis | 28 |
SOFOSBUVIR\VELPATASVIR vs Alternatives: Which Is Safer?
SOFOSBUVIR\VELPATASVIR vs SOFOSBUVIR\VELPATASVIR\VOXILAPREVIR
SOFOSBUVIR\VELPATASVIR vs SOLIFENACIN
SOFOSBUVIR\VELPATASVIR vs SOLIRIS
SOFOSBUVIR\VELPATASVIR vs SOLOSTAR
SOFOSBUVIR\VELPATASVIR vs SOLRIAMFETOL
SOFOSBUVIR\VELPATASVIR vs SOLU-MEDROL
SOFOSBUVIR\VELPATASVIR vs SOMATREM
SOFOSBUVIR\VELPATASVIR vs SOMATROPIN
SOFOSBUVIR\VELPATASVIR vs SONIDEGIB
SOFOSBUVIR\VELPATASVIR vs SORAFENIB
Official FDA Label for SOFOSBUVIR\VELPATASVIR
Official prescribing information from the FDA-approved drug label.